A personalized approach to breathlessness: could a stepped-care program offer relief for lung cancer patients?
NCT ID NCT07728773
First seen Jul 27, 2026 · Last updated Jul 30, 2026 · Updated 3 times
Summary
Shortness of breath, or dyspnea, affects most lung cancer patients and often persists despite standard treatments. This pilot study tests a stepped-care behavioral intervention called INSPIRE, which starts with brief coping skills and adds more intensive psychological support only if needed. Researchers are enrolling 10 adults with lung cancer to see if the program is feasible, well-received, and shows early promise in improving breathing-related distress.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- a stepped-care cognitive-behavioral intervention called INSPIRE
- What this could lead to
- If successful, this approach could offer a personalized, resource-efficient way to ease breathing difficulties in lung cancer patients and reduce reliance on opioids.
- What could go wrong
- This is a very small pilot study with only 10 participants, so results may not apply broadly. The intervention is new and its effectiveness is not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DYSPNEA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Mass General Brigham
Boston, Massachusetts, 02114, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new immunotherapy combo outsmart advanced lung cancer?
- Double attack on mutant KRAS: can two targeted drugs outsmart resistant cancers?
- Seeing the fight: new imaging tracer may reveal how immune cells attack lung cancer
- Could a bronchial wash detect lung cancer mutations faster?
- Can a targeted pill outsmart a tough lung cancer mutation?
- Which lung biopsy method is safer and more accurate?